SCHEDULE 13G/A: Maverick Capital Discloses 3.1% Stake in Fractyl Health

Maverick Capital, along with its affiliates and Lee S. Ainslie III, reported a 3.1% beneficial ownership stake in Fractyl Health, Inc. as of September 30, 2025.

Summary

• Maverick Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III collectively reported beneficial ownership of 4,248,492 shares of Fractyl Health, Inc. Common Stock.
• This ownership represents 3.1% of Fractyl Health, Inc.'s outstanding Common Stock.
• The ownership percentage is based on 137,044,440 shares of Common Stock outstanding as of October 31, 2025, as reported by Fractyl Health, Inc. in its Quarterly Report on Form 10-Q filed on November 12, 2025.
• The reporting persons share both voting and dispositive power over all 4,248,492 shares.
• Maverick Capital, Ltd. acts as an investment advisor for various funds, including Maverick Fund USA, Ltd., Maverick Fund II, Ltd., Maverick Long Enhanced Fund, Ltd, Maverick Long Fund, Ltd., Maverick Designated Investments Fund, L.P., and Maverick Growth Fund, L.P., which collectively hold these shares.
• The securities were not acquired and are not held for the purpose of changing or influencing the control of Fractyl Health, Inc.

Sentiment

Score: 7

Explanation: The disclosure of a significant institutional ownership stake by a reputable firm like Maverick Capital is generally viewed as a positive signal, indicating confidence in the company's value. However, as a passive investment below the 5% threshold, it does not imply active engagement or a change in company control, thus not warranting the highest sentiment score.

Positives

• A significant stake by an institutional investor like Maverick Capital can signal confidence in Fractyl Health, Inc.'s long-term prospects and underlying value.
• The passive nature of the investment, as certified by the reporting persons, indicates a focus on investment returns rather than disruptive corporate control battles.

Future Outlook

NA

Industry Context

This Schedule 13G filing indicates that Maverick Capital, a prominent investment firm, holds a notable passive stake in Fractyl Health, Inc. Such disclosures are routine for institutional investors and provide transparency into significant ownership positions, signaling market participants about institutional interest in the company. While not indicative of operational performance, it reflects an investment decision by a sophisticated entity.

Stakeholder Impact

• Shareholders may view this as a positive indicator of institutional confidence in Fractyl Health, Inc., potentially influencing market perception and trading activity.
• The company's management might see this as validation of their strategy, attracting further institutional interest.

Key Dates

Recommendation

The disclosure of a significant stake by a reputable investment firm like Maverick Capital in Fractyl Health, Inc. suggests institutional confidence in the company's long-term prospects. While not a direct indicator of immediate operational performance or a catalyst for a 'buy' recommendation, it provides a positive signal to the market. Investors should 'hold' and monitor future developments, as this filing primarily reflects an investment position rather than a change in company fundamentals that would warrant a stronger recommendation.

Keywords

Fractyl Health, Maverick Capital, Lee S. Ainslie III, beneficial ownership, Schedule 13G, institutional investment, common stock, equity stake